Skip to content

Mirum Pharmaceuticals

US · MIRM #2051 by market cap Listed 2019
80.64 +1.39 +1.75%
Live - 5344 symbols - heartbeat 69s ago · 2026-10-08 08:09
Pre-market 80.10 -0.67%
After-hours 80.64 0.00%
Market cap
5.24B
P/B
-500.87
EPS
-0.47
Reader sentiment Are you bullish or bearish on MIRM?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    TD Cowen Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $140
    Market Newswire · 2026/8/10
  • Rating change
    RBC Capital Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $148
    Market Newswire · 2026/7/7
  • Rating change
    Analysts Are Bullish on These Healthcare Stocks: Maze Therapeutics, Inc. (MAZE), Mirum Pharmaceuticals (MIRM)
    TipRanks · 2026/9/10
  • Rating change
    A Quick Look at Today's Ratings for Mirum Pharmaceuticals(MIRM.US), With a Forecast Between $118 to $140
    Market Newswire · 2026/8/7
  • Rating change
    J.P. Morgan Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $125
    Market Newswire · 2026/7/2
  • Rating change
    Citi Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $145
    Market Newswire · 2026/9/10
  • Rating change
    A Quick Look at Today's Ratings for Mirum Pharmaceuticals(MIRM.US), With a Forecast Between $135 to $140
    Market Newswire · 2026/8/6
  • Baird Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $130
    Market Newswire · 2026/9/30
  • A Quick Look at Today's Ratings for Mirum Pharmaceuticals(MIRM.US), With a Forecast Between $130 to $195
    Market Newswire · 2026/9/29
  • Rating change
    J.P. Morgan Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $118
    Market Newswire · 2026/8/11
  • Rating change
    J.P. Morgan Keeps Their Buy Rating on Mirum Pharmaceuticals (MIRM)
    TipRanks · 2026/8/11
  • Rating change
    H.C. Wainwright Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $185
    Market Newswire · 2026/8/4
  • H.C. Wainwright Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $195
    Market Newswire · 2026/9/30
  • Rating change
    A Quick Look at Today's Ratings for Mirum Pharmaceuticals(MIRM.US), With a Forecast Between $145 to $185
    Market Newswire · 2026/6/15
  • Rating change
    H.C. Wainwright Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $140
    Market Newswire · 2026/8/21
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM) and Hinge Health, Inc. Class A (HNGE)
    TipRanks · 2026/6/11
  • Rating change
    Morgan Stanley Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $150
    Market Newswire · 2026/6/16
  • Citi Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $160
    Market Newswire · 2026/9/30
  • Rating change
    J.P. Morgan Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Cuts Target Price to $118
    Market Newswire · 2026/8/7
  • J.P. Morgan Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating
    Market Newswire · 2026/9/29

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 08:09:09 · For reference only, not investment advice and not tailored to your situation.